Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines

BACKGROUND: Bronchial carcinoids are pulmonary neuroendocrine cell-derived tumors comprising typical (TC) and atypical (AC) malignant phenotypes. The 5-year survival rate in metastatic carcinoid, despite multiple current therapies, is 14-25%. Hence, we are testing novel therapies that can affect the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mokhtari, Reza Bayat, Kumar, Sushil, Islam, Syed S, Yazdanpanah, Mehrdad, Adeli, Khosrow, Cutz, Ernest, Yeger, Herman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848757/
https://www.ncbi.nlm.nih.gov/pubmed/23927827
http://dx.doi.org/10.1186/1471-2407-13-378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848757/
https://www.ncbi.nlm.nih.gov/pubmed/23927827
http://dx.doi.org/10.1186/1471-2407-13-378

Ejemplares similares